Related Experiment Video
Updated: Apr 23, 2026

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
MicroRNA regulation network in colorectal cancer metastasis
Jiao-Jiao Zhou1, Shu Zheng1, Li-Feng Sun1
1Jiao-Jiao Zhou, Shu Zheng, Li-Feng Sun, Department of Surgical Oncology, the Second Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou 310009, Zhejiang Province, China.
Abstract:
Colorectal cancer is the third most common cancer worldwide. Metastasis is a major cause of colorectal cancer-related death. Mechanisms of metastasis remain largely obscure. MicroRNA is one of the most important epigenetic regulators by targeting mRNAs post-transcriptionally. Accumulated evidence has supported its significant role in the metastasis of colorectal cancer, including epithelial-mesenchymal transition and angiogenesis. Dissecting microRNAome potentially identifies specific microRNAs as biomarkers of colorectal cancer metastasis. Better understanding of the complex network of microRNAs in colorectal cancer metastasis provide new insights in the biological process of metastasis and in the potential targets for colorectal cancer therapies and for diagnosis of recurrent and metastatic colorectal cancer.
Insights
MicroRNAs are key epigenetic regulators involved in colorectal cancer metastasis. Understanding microRNA networks offers new therapeutic and diagnostic targets for this widespread disease.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Colorectal cancer (CRC) is a leading global cause of cancer death, with metastasis being the primary driver.
- The intricate mechanisms underlying CRC metastasis are not fully understood.
- MicroRNAs (miRNAs) are crucial epigenetic regulators impacting gene expression post-transcriptionally.
Purpose of the Study:
- To explore the role of microRNAs in colorectal cancer metastasis.
- To identify potential microRNA biomarkers for CRC metastasis.
- To gain insights into therapeutic and diagnostic strategies for metastatic CRC.
Main Methods:
- Analysis of the microRNAome in colorectal cancer.
- Investigating the impact of miRNAs on epithelial-mesenchymal transition (EMT) and angiogenesis.
- Correlating miRNA expression profiles with metastatic potential.
Main Results:
- MicroRNAs play a significant role in key metastatic processes like EMT and angiogenesis in CRC.
- Dissecting the microRNAome can identify specific miRNAs associated with CRC metastasis.
- Evidence supports miRNAs' involvement in the biological pathways of CRC spread.
Conclusions:
- MicroRNAs are critical players in colorectal cancer metastasis.
- The microRNAome holds potential for identifying biomarkers for CRC metastasis.
- Understanding miRNA networks offers novel therapeutic targets and diagnostic approaches for recurrent and metastatic CRC.
Related Concept Videos
MicroRNAs
MicroRNAs
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

